Revlimid 25 MG capsule 100S
Ended Awarded
- Contract number
- SPE2DB25FGC49
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $89,155
Award facts
- Contract value 100% obligated
- $89,155.06 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at approximately $89,200 to AmerisourceBergen Drug Corp for the supply of Revlimid 25 mg capsules (100-count units) on March 14, 2025, with an ultimate completion date of April 4, 2025. This firm fixed-price delivery order, which carries no set-aside designation, was competitively awarded and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal healthcare vendor, is fulfilling this order under its existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999 through December 2026.
This delivery order represents a routine pharmaceutical procurement supporting military and federal healthcare systems. As a prime contractor under the DLA Troop Support Medical IDC, AmerisourceBergen Drug Corp supplies an extensive portfolio of brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains to support Defense Health Agency and other government healthcare customers worldwide. The contract demonstrates the company's established capability to meet federal procurement requirements through open competition and its role as a key supplier within the Defense Logistics Agency's medical supply chain infrastructure.
Quick answers
Who was awarded contract SPE2DB25FGC49?
SPE2DB25FGC49 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on March 14, 2025.
How much is contract SPE2DB25FGC49 worth?
The government has obligated $89,155 on SPE2DB25FGC49.
Is contract SPE2DB25FGC49 an order under another contract?
Yes. SPE2DB25FGC49 is a delivery order under SPE2DB22D2206, an indefinite delivery contract.
Was contract SPE2DB25FGC49 competed?
The extent of competition for SPE2DB25FGC49 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award